PMID: 7538768Jan 1, 1994Paper

Cellular mucins: targets for immunotherapy

Critical Reviews in Immunology
V Apostolopoulos, I F McKenzie

Abstract

Mucins are attracting great interest as potential targets for immunotherapy in the development of vaccines for cancers expressing Mucin 1 (MUC1) (e.g., breast, pancreas, ovary, and others) as there is (1) a 10-fold increase in the amount in adenocarcinomas; (2) an alteration in expression where they become ubiquitous, and (3) due to altered glycosylation, new epitopes appear on the cell surface that are absent in normal tissues. These new epitopes can be carbohydrate; others are peptide in nature. The cloning of the cDNAs from mucins, particularly MUC1, has led to rapid advances being made, and it is clear that a highly immunogenic peptide exists within the variable number of tandem repeats (VNTR) found in all mucins. This peptide is immunogenic in mice, giving rise to strong antibody production, and most monoclonal antibodies made to breast cancer, which react with the protein core, react with the peptide APDTR. It is now also clear that humans with breast cancer have, in their draining lymph nodes, precursors of cytotoxic T cells that can be stimulated in vitro to react against breast cancer and indeed against the APDTR or a closely related peptide--shown from antibody-blocking studies. These CTLs are unique in that they are ...Continue Reading

Citations

Feb 28, 1998·Immunologic Research·T Kieber-Emmons
Mar 8, 2005·Cancer Immunology, Immunotherapy : CII·Sonja OffnerBirgit Kohleisen
May 3, 2005·Cancer Immunology, Immunotherapy : CII·J WiereckyP Brossart
Apr 6, 1999·Pharmacology & Therapeutics·B R MinevM S Mitchell
Jun 6, 2003·Cancer Treatment Reviews·Joseph M KaminskiBoris Minev
Feb 15, 2011·American Journal of Therapeutics·Marijo Bilusic, Ravi A Madan
Jan 15, 2009·Cancer Research·Zdravka MedarovaAnna Moore
Feb 12, 1998·The Journal of Clinical Investigation·V KaranikasI F McKenzie
Jun 9, 1999·Proceedings of the National Academy of Sciences of the United States of America·S MaoK D Janda
Apr 28, 2010·Expert Opinion on Biological Therapy·Shifang YuanWei Han
Oct 26, 1999·Immunobiology·M Zöller, S Matzku
Aug 22, 2015·Cellular and Molecular Life Sciences : CMLS·Vasso ApostolopoulosSharron E Gargosky
Nov 12, 2009·BioFactors·Satyanarayana RachaganiSurinder K Batra
Dec 3, 2014·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Jenny ZilberbergRobert Korngold
Sep 19, 2000·The Journal of Urology·M S Steiner, J R Gingrich
Aug 30, 2001·Hematology/oncology Clinics of North America·S F Slovin
Jan 16, 2013·Asian Pacific Journal of Cancer Prevention : APJCP·Yu-Qian WangWei Kong
Dec 9, 2014·Human Vaccines & Immunotherapeutics·Gregory T WurzMichael W DeGregorio
Jan 3, 2009·Molecular Immunology·Eliada LazouraVasso Apostolopoulos
Feb 13, 2013·Carbohydrate Polymers·A T LewisP D Lewis
Dec 21, 2004·International Journal of Cancer. Journal International Du Cancer·Jung-Ah ChoChul-Woo Kim
May 21, 2005·Nature Reviews. Cancer·Dan Laheru, Elizabeth M Jaffee
Nov 14, 1997·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·Y CaoU Karsten
May 20, 2003·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·Nuno T MarcosCelso A Reis
Dec 17, 1997·International Journal of Cancer. Journal International Du Cancer·H AkashiK Imai
Jun 29, 2004·International Journal of Cancer. Journal International Du Cancer·John SotiriadisYoon Berm Kim
Mar 22, 1996·The Journal of Biological Chemistry·A BergeronY Fradet
Jan 12, 2016·Therapeutic Advances in Medical Oncology·Gregory T WurzMichael W DeGregorio
Feb 1, 1997·Hybridoma·T Kieber-EmmonsZ Steplewski
Mar 4, 1998·Journal of Hematotherapy·A J Troy, D N Hart
Jul 14, 2000·Journal of Hematotherapy & Stem Cell Research·J Barrett, R Childs
Jul 11, 2006·Immunology·Kuo-Ching ShengVasso Apostolopoulos

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.